北京一家醫院的100多名COVID_19患者正在接受間充質幹細胞注射幫助他們抵禦疾病。實驗性治療是正在進行的臨床試驗的一部分，協調員說該試驗已顯示出緩解COVID_19症狀的早期望。

More than 100 COVID_19 patients at a hospital in Beijing are receiving injections of mesenchymal stem cells to help them fend off the disease.The experimental treatment is part of an ongoing clinical trial, which coordinators say has shown early promise in alleviating COVID_19 symptoms.

研究人員迄今只報告了北京友安醫院7名接受幹細胞治療的患者的結果，每位患者都出現COVID_19症狀，包括發燒和呼吸困難。在1月23日至2月16日的某個時候，他們都各自接受了一次間中皮幹細胞的注射。幾天後調查人員說，所有七名患者的症狀都消失了，他們報告沒有副作用。
Researchers have so far reported results from only seven patients treated with stem  cells at Beijing You'an Hospital. Each patient suffered from COVID_19 symptoms including fevers and difficulty breathing. They each received a single infusion of mesenchymal stem cells sometime between 23 January and 16 February.A few days later,investigators say,all symptoms disappeared in all seven patients.They reported no side effects.

研究小組在3月13日的“衰老與疾病”雜誌上公布了這些結果。Texas A&M 大學再生醫學研究所的Ashok Shetty在一篇附帶的社論中寫到“整體改善是非常了不起的”。但表示需要更大的臨床試驗來驗證這些發現。

The team published those results in the journal Aging & Disease on 13 March.In an accompanying editorial. AshokShetty of TexasA&M University's Institute for Regenerative Medicine wrote "the overall improvement was quite extraordinary"but stated that larger clinical trials were needed to validate the findings.
 

該試驗的主管，北德克薩斯大學健康科學中心的藥理學和神經科學教授金昆林說，他的研究小組目前尚未公開來自另外31名接受該治療的COVID_19患者的數據。在他聲稱，每種情況下治療後症狀都會改善。他說：“我認為結果非常有希望。”金昆林表示，目前有120名COVID_19患者正在北京接受間充質幹細胞注射試驗。
Kun lin Jin, a lead author in the trial and professor of pharmacology and neuroscience at the University of North Texas Health Science Center, says his group now has unpublished data from 31 additional COVID_19 patients who received the treatment.In every case, he claims, their symptoms improved after treatment."I think the results are very promising."he says.According to Jin, 120 COVID_19 patients are now receiving mesenchymal stem cell injections in Beijing for the trial.

金昆林本人並不認為大多數COVID_19患者都應該接受幹細胞輸注。“他認為，對於中度患者而言，也許不需要幹細胞治療。”“對於威脅生命的情況，如果沒有其他藥物可用，我認為使用間充質幹細胞治療至關重要。”